TD Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $249M | Sell |
1,971,583
-1,400,496
| -42% | -$185M | 0.22% | 94 |
|
|
2026
Q1 | $470M | Buy |
3,372,079
+14,339
| +0.4% | +$2.01M | 0.38% | 53 |
|
|
2025
Q4 | $412M | Sell |
3,357,740
-67,251
| -2% | -$8.17M | 0.33% | 59 |
|
|
2025
Q3 | $380M | Buy |
3,424,991
+4,315
| +0.1% | +$490K | 0.31% | 71 |
|
|
2025
Q2 | $379M | Buy |
3,420,676
+1,056,474
| +45% | +$112M | 0.32% | 64 |
|
|
2025
Q1 | $265M | Buy |
2,364,202
+1,271,497
| +116% | +$131M | 0.24% | 82 |
|
|
2024
Q4 | $101M | Buy |
1,092,705
+313,259
| +40% | +$28.2M | 0.09% | 198 |
|
|
2024
Q3 | $65.2M | Buy |
779,446
+52,289
| +7% | +$3.99M | 0.06% | 272 |
|
|
2024
Q2 | $49.9M | Sell |
727,157
-328,023
| -31% | -$21.9M | 0.05% | 300 |
|
|
2024
Q1 | $77.3M | Buy |
1,055,180
+25,523
| +2% | +$1.96M | 0.07% | 235 |
|
|
2023
Q4 | $83.4M | Buy |
1,029,657
+256,039
| +33% | +$19.9M | 0.08% | 208 |
|
|
2023
Q3 | $58M | Sell |
773,618
-118,000
| -13% | -$9.08M | 0.07% | 219 |
|
|
2023
Q2 | $68.7M | Sell |
891,618
-101,640
| -10% | -$8.11M | 0.08% | 202 |
|
|
2023
Q1 | $82.4M | Sell |
993,258
-8,544
| -0.9% | -$708K | 0.1% | 169 |
|
|
2022
Q4 | $86M | Sell |
1,001,802
-29,329
| -3% | -$2.32M | 0.11% | 164 |
|
|
2022
Q3 | $65M | Buy |
1,031,131
+10,208
| +1% | +$644K | 0.08% | 190 |
|
|
2022
Q2 | $63.1M | Buy |
1,020,923
+86,772
| +9% | +$5.37M | 0.07% | 208 |
|
|
2022
Q1 | $55.5M | Buy |
934,151
+59,414
| +7% | +$3.8M | 0.05% | 270 |
|
|
2021
Q4 | $63.5M | Buy |
874,737
+3,222
| +0.4% | +$222K | 0.05% | 273 |
|
|
2021
Q3 | $60.9M | Buy |
871,515
+5,314
| +0.6% | +$373K | 0.06% | 238 |
|
|
2021
Q2 | $59.2M | Buy |
866,201
+115,024
| +15% | +$7.68M | 0.06% | 258 |
|
|
2021
Q1 | $48.5M | Buy |
751,177
+213,988
| +40% | +$13.8M | 0.05% | 277 |
|
|
2020
Q4 | $31.3M | Buy |
537,189
+33,449
| +7% | +$2.02M | 0.04% | 336 |
|
|
2020
Q3 | $31.8M | Buy |
503,740
+127,610
| +34% | +$8.85M | 0.04% | 292 |
|
|
2020
Q2 | $28.9M | Sell |
376,130
-7,402
| -2% | -$567K | 0.04% | 288 |
|
|
2020
Q1 | $28.7M | Sell |
383,532
-16,283
| -4% | -$1.13M | 0.05% | 268 |
|
|
2019
Q4 | $26M | Sell |
399,815
-36,836
| -8% | -$2.4M | 0.04% | 338 |
|
|
2019
Q3 | $27.7M | Sell |
436,651
-25,349
| -5% | -$1.66M | 0.04% | 311 |
|
|
2019
Q2 | $31.2M | Sell |
462,000
-12,428
| -3% | -$818K | 0.05% | 290 |
|
|
2019
Q1 | $30.8M | Sell |
474,428
-66,702
| -12% | -$4.43M | 0.05% | 286 |
|
|
2018
Q4 | $33.8M | Sell |
541,130
-1,364
| -0.3% | -$95.3K | 0.06% | 252 |
|
|
2018
Q3 | $41.9M | Sell |
542,494
-18,122
| -3% | -$1.37M | 0.06% | 246 |
|
|
2018
Q2 | $39.7M | Sell |
560,616
-436,963
| -44% | -$30.9M | 0.06% | 245 |
|
|
2018
Q1 | $75.2M | Sell |
997,579
-43,349
| -4% | -$3.45M | 0.12% | 157 |
|
|
2017
Q4 | $74.6M | Sell |
1,040,928
-7,377
| -0.7% | -$560K | 0.11% | 157 |
|
|
2017
Q3 | $84.9M | Buy |
1,048,305
+100,243
| +11% | +$7.67M | 0.13% | 134 |
|
|
2017
Q2 | $67.1M | Sell |
948,062
-59,650
| -6% | -$3.97M | 0.11% | 156 |
|
|
2017
Q1 | $68.4M | Buy |
1,007,712
+7,493
| +0.7% | +$527K | 0.11% | 153 |
|
|
2016
Q4 | $71.6M | Sell |
1,000,219
-137,331
| -12% | -$10.2M | 0.12% | 146 |
|
|
2016
Q3 | $90M | Sell |
1,137,550
-1,645,010
| -59% | -$134M | 0.16% | 122 |
|
|
2016
Q2 | $232M | Sell |
2,782,560
-434,417
| -14% | -$38.6M | 0.42% | 48 |
|
|
2016
Q1 | $296M | Sell |
3,216,977
-43,209
| -1% | -$3.9M | 0.55% | 33 |
|
|
2015
Q4 | $330M | Buy |
3,260,186
+26,194
| +0.8% | +$2.73M | 0.65% | 30 |
|
|
2015
Q3 | $318M | Buy |
3,233,992
+353,203
| +12% | +$39.2M | 0.63% | 31 |
|
|
2015
Q2 | $337M | Buy |
2,880,789
+1,302,519
| +83% | +$142M | 0.6% | 31 |
|
|
2015
Q1 | $155M | Buy |
1,578,270
+30,774
| +2% | +$3.12M | 0.28% | 64 |
|
|
2014
Q4 | $146M | Sell |
1,547,496
-192,398
| -11% | -$19.9M | 0.24% | 78 |
|
|
2014
Q3 | $185M | Buy |
1,739,894
+99,156
| +6% | +$9.71M | 0.32% | 59 |
|
|
2014
Q2 | $136M | Sell |
1,640,738
-155,026
| -9% | -$12.1M | 0.23% | 77 |
|
|
2014
Q1 | $127M | Buy |
1,795,764
+583
| +0% | +$45.7K | 0.23% | 78 |
|
|
2013
Q4 | $135M | Sell |
1,795,181
-10,679
| -0.6% | -$744K | 0.25% | 74 |
|
|
2013
Q3 | $113M | Sell |
1,805,860
-16,485
| -0.9% | -$985K | 0.23% | 82 |
|
|
2013
Q2 | $93.3M | Buy |
+1,822,345
| New | +$95M | 0.2% | 90 |
|
Other funds holding GILD
VCM
VPM
TD Asset Management's GILD Position: Q2 2026 in Review
TD Asset Management reduced its Gilead Sciences (GILD) stake by 42% in Q2 2026, selling an estimated $185M and leaving 1,971,583 shares worth $249M. The position accounts for 0.22% of the portfolio, ranked #94.
TD Asset Management first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $470M in Q1 2026. 1,917 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- TD Asset Management held 1,971,583 shares of Gilead Sciences worth $249M as of Q2 2026.
- TD Asset Management sold 1,400,496 Gilead Sciences shares in Q2 2026, an estimated $185M.
- Gilead Sciences made up 0.22% of TD Asset Management's portfolio in Q2 2026, its #94 holding.
- TD Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- TD Asset Management's Gilead Sciences position peaked at $470M in Q1 2026.
- 1,917 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.